HUM

HUM

USD

Humana Inc. Common Stock

$231.800+1.210 (0.525%)

Prix en Temps Réel

Healthcare
Healthcare Plans
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$230.590

Haut

$232.085

Bas

$227.760

Volume

1.51M

Fondamentaux de l'Entreprise

Capitalisation Boursière

28.0B

Industrie

Healthcare Plans

Pays

United States

Statistiques de Trading

Volume Moyen

1.76M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $212.45Actuel $231.800Haut $406.46

Actualités Connexes

BusinessWire

Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age

Presenting sponsor of the National Senior Games announces the Humana Game Changer Class of 2025 As the presenting sponsor of the 2025 National Senior Games, leading health and well-being company Humana Inc. (NYSE:HUM)

Voir plus
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age
Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $273 to $268.

Voir plus
Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268
PR Newswire

New PPO Dental Plans More Competitive Against HMOs

DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum...

Voir plus
New PPO Dental Plans More Competitive Against HMOs
PR Newswire

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. ("Humana") (NASDAQ: HUM), resulting...

Voir plus
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Reuters

Wall Street's potential winners and losers from Trump's tax bill

As President Donald Trump's sweeping tax-cut and spending bill heads to the Senate, analysts examine how his broad-ranging policies could turn the fortunes of U.S. companies if the package is enacted as law.

Voir plus
Wall Street's potential winners and losers from Trump's tax bill
Reuters

Humana to back curbs to Medicare Advantage billing practices, WSJ reports

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it.

Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $273

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $322 to $273.

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.